Inventor · disambiguated record
Kristen Picha
Also filed as: PICHA KRISTEN · PICHA KRISTEN M
14 granted patents·12 pending applications·118 citations·filing 2005–2021
92Inventor score
Top patents by PatentIndex Score
26 records- 0190US9695228B2EGFR and c-Met fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2013·Granted Jul 4, 2017·15 cites·9 claims
- 0290US8043616B2sRAGE mimetibody, compositions, methods and usesCENTOCOR INC·Filed 2008·Granted Oct 25, 2011·15 cites·5 claims
- 0389US10662235B2Cysteine engineered fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2017·Granted May 26, 2020·4 cites·15 claims
- 0489US8394378B2Antibodies binding human collagen IIKEHOE JOHN·Filed 2011·Granted Mar 12, 2013·18 cites·5 claims
- 0589US7833531B2Method for treating insulin sensitivity by long-acting GLP-1 receptor mimetibody agonistsCENTOCOR INC·Filed 2007·Granted Nov 16, 2010·14 cites·8 claims
- 0688US8389689B2Anti-GLP-1R antibodies and their usesO'NEIL KARYN·Filed 2010·Granted Mar 5, 2013·9 cites·7 claims
- 0787US8883447B2Anti-GLP-1R antibodies and their usesJANSSEN BIOTECH INC·Filed 2013·Granted Nov 11, 2014·5 cites·8 claims
- 0886US8153583B2Toll like receptor 3 antagonists, methods and usesCARTON JILL M·Filed 2005·Granted Apr 10, 2012·22 cites·9 claims
- 0983US9725497B2EGFR and C-Met fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2013·Granted Aug 8, 2017·5 cites·13 claims
- 1077US8071103B2Pharmaceutical composition comprising a human GLP-1 mimetibodyO'NEIL KARYN T·Filed 2007·Granted Dec 6, 2011·5 cites·2 claims
- 1175US8906649B2Antibodies binding human collagen IIJANSSEN BIOTECH INC·Filed 2013·Granted Dec 9, 2014·2 cites·5 claims
- 1274US12304939B2EGFR and C-met fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2021·Granted May 20, 2025·0 cites·8 claims
- 1368US7812121B2GLP-2 mimetibodies, polypeptides, compositions, methods and usesBAKER AUDREY E·Filed 2007·Granted Oct 12, 2010·4 cites·10 claims
- 1465US10954284B2EGFR and c-Met fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2017·Granted Mar 23, 2021·0 cites·6 claims
- 1558US2020325210A1Cysteine engineered fibronectin type iii domain binding moleculesJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 1656US2024025992A1Proteins comprising delta-like ligand 3 (dll3) antigen binding domains and their usesJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 1749US2006084145A1sRAGE mimetibody, compositions, methods and usesANDERSON GLENN M·Filed 2005·Application pending·0 cites
- 1849US2009162375A1Resistin antagonists and their useBLAKE SIMON·Filed 2007·Application pending·0 cites
- 1948US2007135338A1Human GLP-1 mimetibodies, compositions, methods and usesO'NEIL KARYN·Filed 2005·Application pending·0 cites
- 2048US2010034819A1Human epo mimetic hinge core mimetibodies, compositions, methods and uses for preventing or treating glucose intolerance related conditions on renal disease associated anemiaCENTOCOR INC·Filed 2007·Application pending·0 cites
- 2142US2012189643A1Toll Like Receptor 3 Antagonists, Methods and UsesCARTON JILL M·Filed 2012·Application pending·0 cites
- 2239US2010183592A1Human epo receptor agonists, compositions, methods and uses for preventing or treating glucose intolerance related conditionsJAMES IAN E·Filed 2007·Application pending·0 cites
- 2339US2012082669A1Human epo mimetic hinge core mimetibodies, compositions, methods and uses for preventing or treating glucose intolerance related conditions or renal disease associated anemiaJAMES IAN E·Filed 2011·Application pending·0 cites
- 2438US2007128193A1GLP-1 agonists, compositions, methods and usesO'NEIL KARYN T·Filed 2005·Application pending·0 cites
- 2536US2011071277A1Resistin antagonists and their useBLAKE SIMON·Filed 2010·Application pending·0 cites
- 2633US2007212355A1GLP-2 Mimetibodies, Polypeptides, Compositions, Methods and UsesBAKER AUDREY E·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kristen Picha files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →